Ithaca, NY, United States of America

Aaron Sin

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Cornell University. Active years: 2005-2017.

USPTO Granted Patents = 5 

% Patents Active = 40.0


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 97(Granted Patents)


Location History:

  • Brighton, MA (US) (2005)
  • Ithaca, NY (US) (2007 - 2017)

Company Filing History:


Years Active: 2005-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Aaron Sin in Pharmacokinetic-Based Cell Culture Systems

Introduction

Aaron Sin is an accomplished inventor based in Ithaca, NY (US). He has made significant contributions to the field of pharmacokinetics through his innovative inventions. With a total of 5 patents, his work focuses on enhancing cell culture systems to better mimic in vivo conditions.

Latest Patents

Among his latest patents, Aaron Sin has developed devices and methods for pharmacokinetic-based cell culture systems. One notable invention is a cell culture device that comprises a microscale chamber designed to maintain cells under conditions that yield pharmacokinetic parameters comparable to those observed in vivo. This device allows for the flow of culture medium and focuses on parameters such as tissue size ratio, drug residence time, and liquid to cell ratio. Another significant patent involves a cell culture method utilizing an in vitro microscale cell culture device. This method ensures that the liquid residence time for cells in culture is comparable to that of similar cells in vivo, thereby enhancing the accuracy of metabolic studies.

Career Highlights

Aaron Sin is affiliated with Cornell University, where he continues to push the boundaries of research in cell culture technology. His work has been instrumental in bridging the gap between in vitro and in vivo studies, making significant strides in pharmacokinetic research.

Collaborations

Some of his notable coworkers include Michael L. Shuler and Gregory T. Baxter, who have collaborated with him on various projects aimed at advancing the field of pharmacokinetics.

Conclusion

Aaron Sin's innovative contributions to pharmacokinetic-based cell culture systems are paving the way for more accurate and effective research methodologies. His work not only enhances our understanding of cellular behavior but also holds promise for future advancements in biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…